Institutional investors purchased a net $519.8 thousand shares of ALIM during the quarter ended June 2015 and now own 51.83% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTH RUN CAPITAL LP Bought 473.3 Thousand shares of Alimera Sciences Inc